期刊文献+

喉癌中Fas、FasL和Fas相关死亡结构域蛋白的表达及其意义 被引量:2

Significance of Fas, FasL and FADD expression in squamous cell carcinoma of larynx
下载PDF
导出
摘要 目的研究细胞凋亡调控因子Fas、FasL和Fas相关死亡结构域蛋白(Fas-associated death domain protein,FADD)基因在喉癌中的表达及其意义。方法免疫组化法检测喉癌及癌旁组织中Fas、FasL和FADD表达。结果喉癌组织中Fas、FADD阳性表达率显著低于癌旁组织,FasL阳性表达率显著高于癌旁组织(P<0.05);高分化鳞状细胞癌(简称鳞癌)Fas阳性表达率显著高于中低分化鳞癌(P<0.05),高分化鳞癌FasL阳性表达率显著低于中低分化鳞癌(P<0.05);FADD阳性表达率与肿瘤有无淋巴结转移密切相关(P<0.05)。Fas与FADD蛋白表达之间呈显著正相关(r=0.43,P<0.05)。结论检测喉癌组织中Fas、FasL、FADD表达对评价喉癌的恶性程度、预后及治疗有重要意义。 OBJECTIVE To investigate the expression and significance of Fas, FasL and FADD in laryngeal carcinoma. METHODS Immunohistochemical method was used to examine the expression of Fas, FasL and FADD in laryngeal carcinoma specimen and adjacent normal tissues. RESULTS The positive rates of Fas and FADD in laryngeal carcinoma tissue were significantly lower than that in adjacent normal tissue, while FasL in laryngeal carcinoma tissue was higher than that in adjacent normal tissue(P〈0.05). The Fas-positive rate of the high differentiation group was higher than that of the moderate and low differentiation group,while the FasL-positive rate displayed reverse results(P〈0.05). However, FADD was positively related to the tumor metastasis(P〈0.05).There was significant correlation between Fas and FADD(r=0.43, P〈0.05).CONCLUSION The detection of the expression of Fas, FasL and FADD is of great significance for evaluating the malignant degree, prognosis of laryngeal carcinoma and making decision of the treatment.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2010年第7期343-345,共3页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 喉肿瘤 鳞状细胞 凋亡调节蛋白质类 细胞凋亡 Laryngeal Neoplasms Carcinoma Squamous Apoptosis Regulatory Proteins Apoptosis
  • 相关文献

参考文献13

二级参考文献40

  • 1郑佳,刘复强.Fas/FasL及其临床意义[J].首都医科大学学报,2004,25(3):411-414. 被引量:11
  • 2钱敏飞,王家东,郑璐滢.p27、p53和Bcl-2蛋白在喉癌和切缘组织中的表达[J].中国耳鼻咽喉头颈外科,2005,12(11):721-724. 被引量:5
  • 3向青,徐波,徐梅.Fas/FasL途径介导的人肺癌细胞免疫逃逸[J].中国病理生理杂志,2006,22(1):168-171. 被引量:15
  • 4宿杰,田大力,陈东义,张林,孙丽华.Fas/FasL在小细胞肺癌和转移淋巴结中的表达及临床意义[J].中国医科大学学报,2006,35(3):282-283. 被引量:5
  • 5刘晓红,王心明,王延龄.Fas/FasL在乳腺疾病发生发展过程中作用的研究[J].中国实验诊断学,2007,11(2):158-162. 被引量:10
  • 6Suda T, Takahashi T, Golstein P, et al. Molecular cloning and expressit on of the Fas ligand, a novel member of the tumor necrosis factor family [J]. Ce11,1993,75:1169- 1178.
  • 7Bennett MW, O'connell J, O'sullivan GC, et al. The Fas counterattack in vivo: apoptotic depletion of tumor- infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma[ J]. J Immunol, 1998, 160( 11 ):5669- 5675.
  • 8Trauth BC, Klas C, Peters AM J, et al. Monoclonal antibody mediated tumor regression by induction of apoptosis[ J ]. Science, 1989,245:301 - 305.
  • 9Yonehava S, Ishii A, Yonehara M .A cell killing monoclonal antibody (anti - Fas) to a cell surface antigen co - down regulated with the receptor of tumor necrosis factor [ J]. J Exp Med, 1989,169:1747- 1756.
  • 10Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of Apo - 1, a new member of the nerve growth factor / tumor necros is factor receptor superfamily, in normal and neoplastic cells [J]. Lab Invest, 1993,6 9(4):415 -429.

共引文献38

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部